Medtronic AngioLink Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $42.3M

Medtronic AngioLink General Information

Description

Developer of wound management and wound closure products. The company offers EVS vascular closure system, an arterial stapling device for use in closing holes and punctures made in arteries in connection with the catheter-based surgical procedures, such as angioplasty and angiograms.

Contact Information

Formerly Known As
AngioLink Corporation
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 125 John Hancock Road
  • Suite Six
  • Taunton, MA 02780
  • United States
+1 (508)
Primary Industry
Surgical Devices
Acquirer
Medtronic
Corporate Office
  • 125 John Hancock Road
  • Suite Six
  • Taunton, MA 02780
  • United States
+1 (508)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medtronic AngioLink Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Nov-2004 $42.3M Completed Generating Revenue
2. Early Stage VC (Series B) 09-Sep-2003 Completed Generating Revenue
1. Early Stage VC (Series A) 28-Jan-2002 $7.4M $7.4M Completed Product Development
To view Medtronic AngioLink’s complete valuation and funding history, request access »

Medtronic AngioLink Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
series A1
Series A 1,250,000 $0.001000 $7 $7 1x $5.81 8.9%
To view Medtronic AngioLink’s complete cap table history, request access »

Medtronic AngioLink Patents

Medtronic AngioLink Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2005014056-A2 Advanced wound site management systems and methods Inactive 06-Aug-2003
WO-2005014056-A3 Advanced wound site management systems and methods Inactive 06-Aug-2003
AU-2003279226-A1 Advanced wound site management systems and methods Inactive 21-Jun-2002
EP-1515648-A1 Advanced wound site management systems and methods Inactive 21-Jun-2002
WO-2004000133-A1 Advanced wound site management systems and methods Inactive 21-Jun-2002 A61B17/064
To view Medtronic AngioLink’s complete patent history, request access »

Medtronic AngioLink Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioVentures Investors Venture Capital Minority
IDP Industrial Development Partners Growth/Expansion Minority
IDP Investments Venture Capital Minority
JHK Investments Real Estate Minority
To view Medtronic AngioLink’s complete investors history, request access »

Medtronic AngioLink FAQs

  • When was Medtronic AngioLink founded?

    Medtronic AngioLink was founded in 1999.

  • Where is Medtronic AngioLink headquartered?

    Medtronic AngioLink is headquartered in Taunton, MA.

  • What industry is Medtronic AngioLink in?

    Medtronic AngioLink’s primary industry is Surgical Devices.

  • Is Medtronic AngioLink a private or public company?

    Medtronic AngioLink is a Private company.

  • What is the current valuation of Medtronic AngioLink?

    The current valuation of Medtronic AngioLink is .

  • What is Medtronic AngioLink’s current revenue?

    The current revenue for Medtronic AngioLink is .

  • How much funding has Medtronic AngioLink raised over time?

    Medtronic AngioLink has raised $21M.

  • Who are Medtronic AngioLink’s investors?

    BioVentures Investors, IDP Industrial Development Partners, IDP Investments, and JHK Investments have invested in Medtronic AngioLink.

  • When was Medtronic AngioLink acquired?

    Medtronic AngioLink was acquired on 01-Nov-2004.

  • Who acquired Medtronic AngioLink?

    Medtronic AngioLink was acquired by Medtronic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process